Top biotech stocks gain followers with positive news on drug candidates and potential mergers

From StockTwits: 2025-02-23 22:14:14

Investors on Stocktwits are focusing on these five biotech stocks that saw significant increases in followers last week. Candel Therapeutics Inc. gained 13% more followers as analysts highlighted the potential of its lead cancer drug candidate, CAN-2409, with a 35% year-to-date increase in stock. Acelyrin Inc. had a 12% jump in followers after receiving an unsolicited acquisition offer and announcing a merger agreement with Alumis. Solid Biosciences Inc. saw an 11% increase in followers after positive early-stage data for its gene therapy candidate, with a 43% year-to-date stock increase. Estrella Immunopharma Inc. gained 11% more followers after a bullish rating from D. Boral Capital and progress in its Phase I/II trial, with a 22% year-to-date stock increase. Aditxt Inc. had a 10% increase in followers as its subsidiary prepares for an initial public offering to support the launch of its Mitomic Technology platform for early cancer detection, despite a 53% year-to-date stock decrease.



Read more at StockTwits: Top 5 Biotech Stocks That Saw Biggest Retail Following Jump Last Week